Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Arcutis Biotherapeutics
Arcutis Biotherapeutics
Arcutis boasts positive data for topical Phase III candidate Roflumilast
Clinical Trials Arena
Fri, 11/18/22 - 11:36 am
Arcutis Biotherapeutics
roflumilast
clinical trials
One down, one to go: Arcutis' repurposed AstraZeneca drug clears first PhIII eczema trial
Endpoints
Tue, 11/15/22 - 06:35 pm
Arcutis Biotherapeutics
eczema
clinical trials
roflumilast
With first drug on the market, Arcutis forks over $16M cash for a buyout
Endpoints
Thu, 09/8/22 - 10:56 am
M&A
Arcutis Biotherapeutics
Ducentis BioTherapeutics
With ‘bold experiment’ in drug pricing, Arcutis aims to stand out in plaque psoriasis
MedCity News
Tue, 08/2/22 - 10:38 am
Arcutis Biotherapeutics
Zoryve
plaque psoriasis
drug pricing
FDA Action Alert: Incyte, Arcutis Await Decisions in Vitiligo, Psoriasis
BioSpace
Mon, 07/18/22 - 10:22 am
FDA
Incyte
Arcutis Biotherapeutics
Opzelura
vitiligo
roflumilast
psoriasis
Arcutis showcases positive PhIII data showing its topical cream scratched the sweet spot Otezla or steroids couldn't
Endpoints
Mon, 02/1/21 - 10:54 am
Arcutis Biotherapeutics
clinical trials
ARQ-151
plaque psoriasis
